"Even when the FDA agrees to expanded access, pharmaceutical companies are often reluctant to give terminal patients a drug that is still in development. If patients die from organ failure related to their disease, the FDA may require additional studies from the manufacturer to make sure that the death was not hurried along by the drug. Naturally, the extra studies increase the development timeline and overall cost."
React to this quote
More by Mary Ruwart
See allResonant Thoughts
"So Tom was left alone again, this time for quite a spell. The place had filled up now and he was gradually pushed back from the bar counter until he found himself closely ringed round by men and girls…"
Explore Further
Related Quotes
"Because misery, and degradation, and death, and nothing that God or Satan could inflict would have parted u…"
— Emily Brontë"The Catholic solution of our problem, of our unique vital problem, the problem of the immortality and etern…"
— Miguel de Unamuno"Once muddying subjectivities are removed from the issue, the decision becomes clear."
— Ian McDonald"There are grave misgivings that the discussion on ecology may be designed to distract attention from the pr…"
— Indira Gandhi"Since last night I've had countless threats to cut my head off. I have police over 200 death threats. No ar…"
— Tommy Robinson"If death had only negative aspects, dying would be an unmanageable action."
— Emil Cioran

